Raynovent Announces Receiving of Certificate of Invention Patent in United States

Time:2019.07.05Views:19Author:众生睿创

Raynovent received the Certificate of Invention Patent (Hydroxyl purine compounds and applications) issued by United States Patent and Trademark Office.

Previous:Dr. Chen Xiaoxin, Vice President of Raynovent was Appointed as Vice President of China Non-alcoholic Steatohepatitis New Drug Alliance

Next:Raynovent Announces Receiving of Certificate of Invention Patent in United States in Japan

News Center